Clinigen and Cumberland collaborate in mutual market access deal

By Dan Stanton contact

- Last updated on GMT

Clinigen and Cumberland collaborate in mutual market access deal

Related tags: Pharmacology, Medicine

UK-based Clinigen and US-based Cumberland Pharmaceuticals have struck a deal to market each others products outside their respective countries.

Cumberland Pharmaceuticals is a Nashville, Tennessee-based specialty pharma firm with a portfolio of products including acetylcysteine for the treatment of acetaminophen poisoning, and an ibuprofen injection to manage pain available in the US.

Clinigen, meanwhile, is a UK-based firm which markets its own portfolio of niche pharmaceuticals, on top of supplying commercial medicines for clinical trials.

In the accord announced today, both firms will be marketing, promoting and distributing each other’s portfolios in their home markets.

“A key strategic initiative this year has been to develop our Group's global distribution footprint,”​ said Clinigen’s CEO Peter George. “The US is a particular area of focus where we are looking to initiate a long term strategic partnership and Cumberland was a natural fit as a partner.

Working together is a logical move for both companies as we will mutually benefit from each other's distribution expertise and capabilities in our respective regions,” ​he said, while Cumberland’s CEO AJ Kazimi added in a statement the deal “creates a new growth driver for both companies that builds on our strengths.”

Earlier this year, Clinigen was selected by AstraZeneca​ for its global access programme (GAP) to provide access for the investigational antibiotic CAZ-AVI to eligible patients outside the US and Canada.

Related news

Show more

Related products

show more

Keys To A Successful Rapid Commercial Launch

Keys To A Successful Rapid Commercial Launch

Catalent Pharma Solutions | 21-Oct-2020 | Insight Guide

Pharma and biotech companies are dedicating resources to new treatments with the hope of helping patients. The quicker they can get products to patients,...

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Local lab Data Management

Local lab Data Management

Q² Solutions | 01-May-2020 | Data Sheet

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...

Q2 Solutions: Corporate Brochure

Q2 Solutions: Corporate Brochure

Q² Solutions | 17-Apr-2020 | Product Brochure

We are an innovative, progressive and responsive partner with the global experience, medical expertise and focus on quality that is integral to drug, medical...

Related suppliers

Follow us


View more